ALT 0.00% 0.1¢ analytica limited

wiseowl research - 7.6c buy recommendation, page-63

  1. 734 Posts.
    lightbulb Created with Sketch. 51
    I agree it's a very big market and opportunity..imagine having this affliction and being offered the current alternatives vs with PeriCoach? (and personally I would rather use PeriCoach than have to repeatedly visit a clinician, not that I will suffer this affliction as a man!!)

    One thing that's been mulling around in my head is something someone said earlier "once they've used it for a while they wouldn't need it anymore". I have two possible perspectives on that, 1) it's not JUST to train women how to do the exercises, it's to provide data on PROGRESS and it's the second bit that's compelling to keep using it, and 2) I wonder if it could be a bit like a gym membership, where people keep paying because they know they "should" be doing the exercises (also they know their doctor knows if they're not).

    In my opinion, adoption is the most important, attrition will be inevitable, but the above should mitigate that. In terms of uptake, intuitively, there will be women who find it very unappealing and those that see it as a proactive and scientific approach to assisting their problem; like anything there will be a spectrum.

    I will be keenly watching to see how the company markets this product...I don't know the calibre of their marketing team; based on their 4C the wage bill suggests there are not a lot of staff and they'll need some marketing nouse to really sell it to the market. For this type of product it will be a case of push and pull marketing; marketing to doctors/physicians to create push and target marketing to women in the right age range, creating a pull towards physicians who offer it (or women asking their doctor why they don't offer it).
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.